Back to results
US 2023/0143502 A1Published application
Cannabinoid receptor type 2 (cb2) modulators and uses thereof
AssigneeTeon Therapeutics, Inc.
InventorsElfatih Elzein, Jiwen Liu
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds, compositions, and methods for modulating the Cannabinoid receptor 2 (CB2) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or conditions that are mediated by the action of Cannabinoid receptor 2 (CB2) or that we benefit from modulating the Cannabinoid receptor 2 (CB2).
Claims12
1-79. (canceled)
A method for treating cancer in a mammal, the method comprising administering to the mammal a compound selected from:
- 8
- 12
- 13
- 46
- 54
- 59
- 83
- 110
- 115
- 116
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 165
- 166
- 173
- 177
- 180
- or a pharmaceutically acceptable salt or stereoisomer thereof.
25 more elements
81-82. (canceled)
Dependencies are inferred from the claim text.